Undeterred by a definitive clinical-trial failure, Medtronic said it will continue to develop its medical device for high blood pressure in hopes of winning U.S. regulatory approval.
via WSJ.com: US Business http://ift.tt/1lu8zQf
via WSJ.com: US Business http://ift.tt/1lu8zQf
Nessun commento:
Posta un commento